Troy Hospital Health Care Authority

Troy Hospital Health Care Authority was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoTROY HOSPITAL HEALTH CARE AUTHORITY
TROY, AL 36081

33aNPI1770814626assigned 01/15/2010

33bProvider typeRural Acute Care Hospital

28Total paid$2.16M

24GClaims104,524

24DCodes billed64

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Rural Acute Care Hospital providers in Alabama

Rank by total paid#5 of 11

Median peer was paid$1.34M

This provider vs. median1.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	16,107	$213K
2019	16,595	$232K
2020	11,563	$183K
2021	13,891	$257K
2022	14,204	$298K
2023	18,241	$553K
2024incomplete	13,923	$424K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	33%	19,449	17,195	$718K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	19%	7,157	6,134	$404K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	8.9%	1,804	1,664	$191K
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.8%	4,065	3,326	$147K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.5%	576	471	$119K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.1%	11,450	9,795	$89K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	3.8%	2,729	2,434	$83K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	3.6%	724	236	$77K
80053	Comprehensive metabolic panel	3.2%	7,388	6,319	$70K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.3%	3,193	2,620	$28K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	203	167	$28K
80048	Basic metabolic panel (calcium, ionized)	1.0%	2,548	2,199	$22K

52 more codes

83735		<1%	3,461	$19K
81001		<1%	4,937	$14K
71045	Radiologic examination, chest; single view	<1%	3,166	$13K
70450	Computed tomography, head or brain; without contrast material	<1%	174	$13K
87430		<1%	818	$11K
81025		<1%	3,151	$10K
80061	Lipid panel	<1%	591	$10K
87400		<1%	2,088	$10K
84484		<1%	1,809	$9K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	404	$9K
87086	Culture, bacterial; quantitative colony count, urine	<1%	751	$7K
87070		<1%	635	$6K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	118	$6K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	88	$5K
80306		<1%	428	$4K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	138	$4K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	36	$4K
83036	Hemoglobin; glycosylated (A1C)	<1%	186	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	128	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	298	$2K
83690		<1%	382	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	493	$2K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	46	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,745	$2K
71046	Radiologic examination, chest; 2 views	<1%	173	$2K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	38	$2K
87210		<1%	349	$2K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	32	$2K
86803		<1%	43	$969.93
83880		<1%	54	$778.47
81003		<1%	449	$669.90
84439		<1%	54	$666.00
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	13	$570.44
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	85	$448.69
85610		<1%	152	$363.51
86141		<1%	30	$321.20
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	225	$296.31
86318		<1%	30	$234.74
J0780	Injection, prochlorperazine, up to 10 mg	<1%	34	$205.43
87420		<1%	13	$176.44
85730		<1%	136	$169.36
74018		<1%	16	$158.76
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	554	$144.72
80076		<1%	14	$99.36
85027		<1%	28	$91.29
85007		<1%	28	$86.19
82043		<1%	14	$80.04
96361	Intravenous infusion, hydration; each additional hour	<1%	31	$78.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	28	$16.32
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	13	$10.30
36415	Collection of venous blood by venipuncture	<1%	14,414	$8.97
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	0%	117	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCLAFLIN, DEBRA (REVENUE CYCLE DIRECTOR)